Healthcare Distribution Alliance – Patients Move Us.
SEARCH
About
Board of Directors
HDA is governed by a Board of Directors responsible for identification and development of priorities, policies and positions of the organization. The Board of Directors is made up of a corporate officer of each distributor member that chooses to be represented on the Board of Directors.
The president and CEO is an ex officio non-voting member of the Board.
Greg
Drew, RPh
HDA Chairman
President
President
Value Drug Company
Robert
Mauch
HDA Vice Chairman
EVP and Group President
EVP and Group President
AmerisourceBergen Corporation
Fred
Battah
President
Real Value Rx dba Hospital Pharmaceutical Consulting
Dawn
Boyter
Chief Executive Officer
Richie Pharmacal Co., LLC
Michael
Broome
Chief Executive Officer
Mutual Wholesale Drug Company
Paul
Dickson
President
Morris & Dickson Co., L.L.C.
Earl
English
President
CuraScript SD
Saul
Factor, RPh
President
Smith Drug Company, Div. J M Smith Corporation
Michael
Faul
President and CEO
Miami-Luken, Inc.
Louis
Ferraro
Vice President, Generic Pharmaceutical Sourcing and Administration
Henry Schein, Inc.
Scott
Franklin
President
TopRx
Chad
Gielen
President/CEO
Louisiana Wholesale Drug Co. Inc.
Juan Carlos
Hernandez
Executive Vice President & General Manager
Drogueria Betances, LLC
Michael
Holmes
CEO Principal Dynamics & CEO QCP
Quality Care Products, LLC/Principal Dynamics
Sam
Lazich
President
DMS Pharmaceutical Group, Inc.
David
MacFarlane
Chief Executive Officer
Seacoast Medical, LLC
Nishit
Mehta
CEO
HyGen Pharmaceuticals, Inc.
Jacob
Paskes
Member, CEO
BluPax Pharmaceuticals, LLC
Keith
Patek
Vice President - Corporate Strategy & Development
Prodigy Health Supplier Corporation